<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01274494</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-CME-ATA-2010/1</org_study_id>
    <nct_id>NCT01274494</nct_id>
  </id_info>
  <brief_title>COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication</brief_title>
  <official_title>COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this multi-centre survey is to assess treatment adherence and quality of life in a
      Jordanian and Lebanese population newly diagnosed with hypertension or with uncontrolled
      essential hypertension being on antihypertensive treatment for at least 6 months.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Compliance rate</measure>
    <time_frame>6 months</time_frame>
    <description>Identify the percentage of subjects compliant to their antihypertensive treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health Related Quality of Life (MINICHAL Score)</measure>
    <time_frame>6 months</time_frame>
    <description>To compare and identify changes in the quality of life before and after anti-hypertensive treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Type of pharmacological treatments</measure>
    <time_frame>6 months</time_frame>
    <description>To identify the pharmacological treatments used by physicians in Jordan and Lebanon to treat patients newly diagnosed or with uncontrolled hypertension.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Factors affecting adherence to treatment</measure>
    <time_frame>6 months</time_frame>
    <description>To identify associated factors that may alter adherence to anti-hypertensive treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance rate by antihypertensive regimen used</measure>
    <time_frame>6 months</time_frame>
    <description>To compare treatment rate for different antihypertensive regimen used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of controlled patients</measure>
    <time_frame>6 months</time_frame>
    <description>To identify the percentage of patients reaching their target blood pressure according to the JNCVII criteria.</description>
  </secondary_outcome>
  <enrollment type="Actual">1501</enrollment>
  <condition>High Blood Pressure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        multi-centre survey of patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 21 years of age

          -  Patients newly diagnosis with essential hypertension or with hypertension that is
             uncontrolled after being under the same antihypertensive treatment for at least 6
             months (based on the criteria established by the Joint National Committee VII)

          -  Patients capable of providing an informed consent

        Exclusion Criteria:

          -  Patients with secondary hypertension

          -  Pregnant women or nursing mothers

          -  Patients with acute illnesses or psychiatric diagnosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2011</study_first_submitted>
  <study_first_submitted_qc>January 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2011</study_first_posted>
  <last_update_submitted>September 10, 2013</last_update_submitted>
  <last_update_submitted_qc>September 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antihypertensive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

